ArticleESMO gastrointestinal oncology2025
Prognostic factors for overall survival in advanced digestive neuroendocrine carcinoma treated with first-line cisplatin-based chemotherapy: a
H Hirano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.